US46185L1035 - NVTA - A14NKG (XNYS)
INVITAE CORP Share
No Price
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | -97,55 % | -99,90 % |
Company Profile for INVITAE CORP Share
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Company Data for INVITAE CORP Share
Name INVITAE CORP
Company Invitae Corporation
Symbol NVTA
Website https://www.invitae.com
Primary Exchange
NYSE
WKN A14NKG
ISIN US46185L1035
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Kenneth D. Knight
Country United States of America
Currency USD
Employees 1,7 T
Address 1400 16th Street, 94103 San Francisco
IPO Date 2015-02-12
Ticker Symbols
Name | Symbol |
---|---|
NYSE | NVTA |
More Shares
Investors who INVITAE CORP hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.